ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening prostate cancer care, support, and outcomes for veterans. Taking place ...
Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...
Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care. Following the 2025 European Society of Medical Oncology (ESMO) ...
IOWA CITY, Iowa (KWQC) -Prostate cancer remains the most common non-skin cancer in men and the second deadliest after lung cancer, according to the American Association of Cancer Research. As part of ...
According to the American Cancer Society, one in eight American men will be diagnosed with prostate cancer in their lifetime. There will be approximately 314,000 new cases of prostate cancer this year ...
When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results